Doximity Inc (DOCS)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $5.95B
Last updated: Nov 17, 2026 at 4:35 PM ET
Doximity Inc (DOCS) Statistics
Doximity (DOCS) has a market cap of $5.95B and an enterprise value of $5.73B. Its share count is down 4.81% from a year earlier. Its trailing P/E of 29.6x is below its 5-year median of 39.4x.
Total Valuation
Enterprise value is 3.68% below the market cap, as cash exceeds debt.
| Market Cap | $5.95B |
|---|---|
| Enterprise Value | $5.73B |
| Latest price (Nov 17, 2026) | $31.13 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | March |
Valuation Ratios
Sales and book value multiples are 8.4x and 6.0x. Its year-end P/E ranged from 29.5x to 77.1x from 2021 to 2025.
| P/E Ratio | 29.6x |
|---|---|
| Forward P/E | 22.6x |
| P/S Ratio | 8.4x |
| Forward P/S | 8.7x |
| P/B Ratio | 6.0x |
| P/TBV Ratio | 6.8x |
| P/FCF Ratio | 18.7x |
| P/OCF Ratio | 19.5x |
| PEG Ratio | 5.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 23.8x EBITDA and 18.0x free cash flow.
| EV / Earnings | 41.0x |
|---|---|
| EV / Sales | 8.7x |
| EV / EBITDA | 23.8x |
| EV / FCF | 18.0x |
Price Statistics
The stock is down 37.26% over 52 weeks and trades 3.77% above its 50-day average.
| Beta (1Y) | 0.61 |
|---|---|
| 52-Week Change | -37.26% |
| 1-Month Change | -1.02% |
| 3-Month Change | +20.89% |
| 6-Month Change | +61.63% |
| 5-Year Change | -52.85% |
| Total Return (1Y) | -37.26% |
| Total Return (3Y CAGR) | +8.10% |
| Total Return (5Y CAGR) | -13.82% |
| Return vs SPY (1Y) | -45.91% |
| Max Drawdown (1Y) | -65.05% |
| Max Drawdown (3Y) | -78.34% |
| Sharpe Ratio (1Y) | -0.67 |
| Correlation with SPY (1Y) | 0.13 |
| 50-Day Average | $30.00 |
| 200-Day Average | $25.14 |
| 52-Week Range | $17.15 to $51.84 |
| RSI (14 Days) | 45.0 |
| Average Volume (20 Days) | 2.39M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.37x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 6.37x |
|---|---|
| Quick Ratio | 6.37x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 15.05% over the last 12 months, against a 5-year average of 17.38%.
| Return on Equity (ROE) | 15.05% |
|---|---|
| Return on Assets (ROA) | 12.80% |
| ROE (5Y Average) | 17.38% |
| ROA (5Y Average) | 14.86% |
| ROIC (5Y Average) | 17.73% |
| Asset Turnover | 0.56x |
| Receivables Turnover | 3.85x |
Taxes
Income tax took 31.38% of pretax income over the last 12 months.
| Income Tax (TTM) | $63.89M |
|---|---|
| Effective Tax Rate | 31.38% |
Scores
DOCS has an Altman Z-Score of 22.31, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 22.31 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $661.58M over the last 12 months is up 6.48% from the 12 months before.
| Revenue | $661.58M |
|---|---|
| Revenue Growth (YoY) | +6.48% |
| Gross Profit | $574.43M |
| Operating Income | $174.29M |
| Pretax Income | $203.61M |
| Net Income | $139.72M |
| EBITDA | $224.12M |
| Reported EPS (TTM) | $1.05 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 85.18% of the $1.09B in total assets.
| Cash and Equivalents | $218.61M |
|---|---|
| Total Debt | $0 |
| Net Cash | $218.61M |
| Net Cash Per Share | $1.22 |
| Working Capital | $776.95M |
| Shareholder Equity | $928.48M |
| Book Value Per Share | $5.20 |
| Tangible Book Value | $812.07M |
| Tangible Book Per Share | $4.54 |
| Total Assets | $1.09B |
| Total Liabilities | $163.29M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $8.90M of capital spending, operating cash flow left $296.78M of free cash flow.
| Operating Cash Flow | $305.69M |
|---|---|
| Capital Expenditures | $8.90M |
| Free Cash Flow | $296.78M |
| FCF Per Share | $2.33 |
| Depreciation and Amortization | $27.80M |
| Share Repurchases | $433.24M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 26.34%, against a 5-year average of 34.13%.
| Gross Margin | 86.83% |
|---|---|
| Operating Margin | 26.34% |
| Pretax Margin | 30.78% |
| Net Margin | 21.12% |
| EBITDA Margin | 33.88% |
| FCF Margin | 44.86% |
| Gross Margin (5Y Average) | 88.86% |
| Operating Margin (5Y Average) | 34.13% |
| Net Margin (5Y Average) | 34.51% |
Growth
Revenue grew 15.45% a year over 3 years, and EPS 25.41% a year.
| Revenue Growth (3Y CAGR) | +15.45% |
|---|---|
| Revenue Growth (5Y CAGR) | +25.53% |
| EPS Growth (3Y CAGR) | +25.41% |
| EPS Growth (5Y CAGR) | +79.63% |
| FCF Growth (3Y CAGR) | +22.34% |
| FCF Growth (5Y CAGR) | +32.29% |
| Operating Income Growth (3Y CAGR) | +19.77% |
| Book Value Per Share Growth (2Y CAGR) | +4.30% |
| Tangible Book Per Share Growth (2Y CAGR) | +3.07% |
Dividends and Yields
DOCS does not pay a dividend. Its free cash flow yield is 5.34%.
| Earnings Yield | 3.38% |
|---|---|
| FCF Yield | 5.34% |
| Buyback Yield | 7.57% |
| Shareholder Yield | 7.57% |
Peer Position
Against 8 similar companies, DOCS has the 5th highest P/E.
P/E RatioPeer median 30.5x
P/S RatioPeer median 2.0x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +17.02%
| P/E Ratio | 29.6x vs 30.5x median |
|---|---|
| P/S Ratio | 8.4x vs 2.0x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.48% vs +17.02% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.87% and EPS growth at 3.76% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.87% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +3.76% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DOCS
What is DOCS's market cap?
Doximity has a market cap of $5.95B. Its enterprise value, which adds debt and subtracts cash, is $5.73B.
What is DOCS's P/E ratio?
Doximity has a trailing P/E ratio of 29.6x and a forward P/E of 22.6x.
How many shares of DOCS are outstanding?
Doximity has 178.67M shares outstanding. The count is down 4.81% from a year earlier.
Does DOCS pay a dividend?
No. Doximity does not pay a dividend.
How much debt does DOCS have?
Doximity has $0 of total debt and $218.61M of cash and equivalents, a net cash position of $218.61M.
DOCS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts